共 197 条
[41]
Cui W(2017)Empagliflozin and progression of kidney disease in type 2 diabetes Diabetes Care 40 1479-F234
[42]
Li D(2015)Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis Am J Physiol Ren Physiol 309 F227-776
[43]
Ferrannini E(2017)Acute SGLT inhibition normalizes O Diabetes Care 40 771-469
[44]
Del Prato S(2005) tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats Arch Intern Med 165 466-432
[45]
Nauck M(2009)Renal handling of ketones in response to sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes Curr Opin Nephrol Hypertens 18 428-F83
[46]
Duran-Garcia S(2015)Anemia with impaired erythropoietin response in diabetic patients Am J Physiol Ren Physiol 308 F77-63
[47]
Bonner C(2018)Solute carrier family 2, member 9 and uric acid homeostasis Diabetes Metab Syndr 12 59-657
[48]
Kerr-Conte J(2017)Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus N Engl J Med 377 644-375
[49]
Gmyr V(2017)SGLT2 inhibitors-induced electrolyte abnormalities: an analysis of the associated mechanisms J Am Soc Nephrol 28 368-F422
[50]
Ferrannini E(2018)Canagliflozin and cardiovascular and renal events in type 2 diabetes Am J Physiol Ren Physiol 314 F412-621